Global Growth of Epinephrine Autoinjector: Rise in Severe Allergic Reactions Drives Demand

Comments · 3 Views

Global Growth of Epinephrine Autoinjector: Rise in Severe Allergic Reactions Drives Demand

Over the past decade, the rates of food allergies and other severe allergic reactions have been steadily increasing worldwide. These allergic conditions can cause life-threatening anaphylaxis if exposure to an allergen occurs. As awareness has grown of both the rise in allergic reactions and their risks, so too has demand for it.

Epinephrine, also known as adrenaline, is the only recommended first-line treatment for anaphylaxis. It works to rapidly reverse symptoms by constricting blood vessels and relaxing smooth muscles in the lungs and digestive tract. However, administering epinephrine in the midst of anaphylaxis can be challenging without medical training. This is where Epinephrine Autoinjector have proved invaluable.

Epinephrine Autoinjectors Provide Life-saving Treatment

They are pre-filled devices containing a single dose of epinephrine that is automatically injected into the user's thigh muscle with the push of a spring-loaded needle. They were introduced in the 1980s to allow for no-hassle self-administration or use by untrained friends/family in emergency situations.

Early autoinjectors helped drive wider adoption and accessibility of epinephrine treatment. With step-by-step instructions and an easy-to-use design, it transformed anaphylaxis management. They gave severe allergy patients a means to feel secure carrying rescue medication anywhere, and lessened the anxiety of bystanders assisting during reactions.

 

Gets More Insights on, Epinephrine Autoinjector

 

Comments